Cargando…
Are the Currently Existing Anti-Human Papillomavirus Vaccines Appropriate for the Developing World?
Cervical cancer prevention is expected to be achieved by vaccination of girls 2-3 years before sexual debut, and cervical smear cytology follow-up. The existing human papillomavirus (HPV) vaccines target the low-risk 6 and 11, and the high-risk 16 and 18 subtypes, the most common agents of ano-genit...
Autor principal: | van Bogaert, LJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793430/ https://www.ncbi.nlm.nih.gov/pubmed/24116304 http://dx.doi.org/10.4103/2141-9248.117924 |
Ejemplares similares
-
Appropriate human papillomavirus vaccination strategies – Authors' reply
por: Michels, Karin B, et al.
Publicado: (2009) -
Current status of human papillomavirus vaccines
por: Kim, Kwang Sung, et al.
Publicado: (2014) -
Development of World Health Organization (WHO) recommendations for appropriate clinical trial endpoints for next-generation Human Papillomavirus (HPV) vaccines
por: Prabhu, Malavika, et al.
Publicado: (2016) -
Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
por: Akhatova, Ayazhan, et al.
Publicado: (2022) -
Current global status & impact of human papillomavirus vaccination: Implications for India
por: Sankaranarayanan, Rengaswamy, et al.
Publicado: (2016)